10x Genomics Inc - Ordinary Shares - Class A
TXG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.13B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.13 Billion |
|---|---|
| Enterprise Value | $8.73 Billion |
| Earnings per Share | $-0.35 |
| Beta | 1.99 |
| Outstanding Shares | 129,984,169 |
Return
| Return on Equity | -9.10% |
|---|---|
| Return on Assets | -7.29% |
| Return on Invested Capital | -9.60% |
Valuation & Multiples
| P/E Ratio | -118.83 |
|---|---|
| PEG | 78.22 |
| Price to Sales | 16.88 |
| Price to Book Ratio | 11.25 |
| Enterprise Value to Revenue | 14.16 |
| Enterprise Value to EBIT | -99.85 |
| Enterprise Value to Net Income | -117 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.24
Consensus analyst estimateRevenue Estimate
$146.67 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.27
Consensus analyst estimateRevenue Estimate
$147.96 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 16.53% |
|---|---|
| Total Calls | 200▼ 99.97% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.81%▼ 98.20% |
|---|---|
| Total Invested | $326.69M▼ 93.42% |
| Investors Holding | 127▼ 278.00% |
About 10x Genomics Inc
CEO: Serge Saxonov
